Background: The aim of this study was to investigate the association between 25-hydroxyvitamin D and arterial stiffness assessed by brachial-ankle pulse wave velocity (baPWV) in type 2 diabetes mellitus(T2DM).

Methods: We identified 1335 diabetes patients from the Department of Endocrinology, Shanghai Tenth People’s Hospital from 1 November 2017 to 2 November 2019. 603 T2DM patients were included in the cross-sectional study. Participants were divided into two group: AS group (baPWV≥1700cm/s) and the control group (baPWV<1700cm/s). Linear correlation was used to evaluate the relationship between 25-hydroxyvitamin D and baPWV. Multiple linear regression and logistic regression analysis were adopted to investigate risk factors for AS.

Results: 1) Patients with AS tended to be older and had a longer duration of diabetes than control group (P<0.001 and P=0.013). Patients with AS were more likely to have diabetic retinopathy and diabetic peripheral neuropathy than the control (56% vs.43%, P=0.002; 66% vs.52%, P=0.001). 2) Compared to patients without AS, patients with AS showed lower 25-hydroxyvitamin D and higher rate of 25-hydroxyvitamin D deficiency than control group (P=0.020 and P=0.011). 3) No matter in all subjects, males or females, baPWV levels were negatively associated with 25-hydroxyvitamin D levels (r=-0.119, P=0.004; r=-0.107, P=0.044; r=-0.128, P=0.043). 4) Multiple linear regression showed that 25-hydroxyvitamin D was the negatively influencing factor of baPWV in whole sample and males (β=-2.207, P=0.014; β=-2.207, P=0.022). Logistic regression showed that age and SBP were risk factor of AS(OR:1.072, 95% CI: 1.048- 1.097, P<0.001; OR:1.028, 95% CI: 1.017-1.038, P<0.001) while VD was protective factor of AS in T2DM patients(OR:0.987, 95% CI: 0.976-0.998, P=0.024).

Conclusion: There was a negatively relationship between 25-hydroxyvitamin D and arterial stiffness assessed by baPWV. High 25-hydroxyvitamin D was found to be a protective factor for arterial stiffness.

Disclosure

B. Ma: None. Y. Chen: None. X. Wang: None. S. Qu: None.

Funding

National Key R&D Program of China (2018YFC1314100, 2016YFC1305600); Shanghai Outstanding Academic Leaders Plan (049)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.